Previous 10 | Next 10 |
2023-08-14 01:30:00 ET Summary Meridian Growth Fund seeks long-term growth of capital by investing primarily in equity securities of small to mid-capitalization growth companies. With inflation gradually easing and the U.S. economy holding firm, stocks generally advanced during th...
2023-08-08 20:54:11 ET QuidelOrtho Corporation (QDEL) Q2 2023 Earnings Call August 8, 2023 17:00 PM ET Company Participants Bryan Brokmeier - Vice President of Investor Relations Douglas C. Bryant - President and Chief Executive Officer Joseph M. Busky - Chief Fi...
2023-08-08 16:32:04 ET Quidel press release ( NASDAQ: QDEL ): Q2 Non-GAAP EPS of $0.26 in-line. Revenue of $665.1M (+8.4% Y/Y) beats by $50.52M . Second quarter revenue of $665.1 million increased by 8% as reported with non-respiratory revenue up 3% on a supplement...
Highlights Second quarter revenue of $665.1 million increased by 8% as reported with non-respiratory revenue up 3% on a supplemental combined basis (up 4% in constant currency) and respiratory revenue down 74% on a supplemental combined basis Non-respiratory revenue driven by 9% const...
2023-08-07 17:35:56 ET QuidelOrtho ( NASDAQ: QDEL ) is scheduled to announce Q2 earnings results on Tuesday, August 8th, after market close. The consensus EPS Estimate is $0.26 (-88.9% Y/Y) and the consensus Revenue Estimate is $614.58M (+0.2% Y/Y). Over the last ...
2023-08-05 16:00:22 ET The US could see the largest number of approvals for medtech devices in around 10 years given the high number of approvals the US FDA granted in the first half of 2023. The agency's Center for Devices and Radiological Health in H1 approved or cleared 45 new device...
Company receives top customer rating in the 2023 IMV ServiceTrak™ Awards QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion ...
Strategic partnership will add middleware and data management solutions across the company’s diagnostics portfolio QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics techn...
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will report its financial r...
2023-07-13 17:00:40 ET Summary QuidelOrtho, a result of a 2022 business combination, was a strong player in the COVID-19 testing sector, generating $1.3 billion in 2021 from COVID products. The company experienced a dramatic drop in share prices in early 2022, with shares trading ...
News, Short Squeeze, Breakout and More Instantly...
Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600 Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600 PR Newswire NEW YORK , July 23, 2024 /PRNewswir...
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will report its financ...
2024-07-09 04:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...